Johan Buyle

Partner

Philip Corthout

Investment Manager

Sven Haest

Investment Manager

Dimitri Herbosch

Partner

Guy Mertens

Partner

6 past transactions

moonbird

Venture Round in 2021
HealthTech, Mindfulness, Hardware, Better breathing

Twikit

Series A in 2019
Twikit is an enterprise software company with a sharp focus on mass customization and digital manufacturing. We set new standards on how brands and enterprises conceptualize and manufacture products: customizable, on demand and digitally manufactured. The company has its HQ in Antwerp - Belgium and commercial offices in New York City and Stuttgart. The core differentiator of Twikit is the combined knowledge of software, product engineering for digital manufacturing and digital business chains. We work with our partners across the world to enable advanced product individualization by offering seamless end-to-end solutions from ideation to full integration with our enterprise software solutions. Our unique strength is that we integrate product parametrization and UX with digital manufacturing and mass customization at scale into any (existing) business and digital manufacturing flow.

Bluebee

Series A in 2016
Bluebee is a leading provider of high performance genomics solutions, enabling research and clinical labs to substantially reduce cost and time-to-diagnose. Bluebee provides a unique cloud-based accelerated genomics platform to enable fast, efficient and affordable processing of large volumes of genomics data. Genetic analyses are currently undergoing extreme changes as a result of revolutionary developments in next generation DNA sequencing technology. While personalized treatment comes with great promises, routine clinical implementation of whole genome based diagnostics is still faced with major technological and biological challenges: the ever-growing amounts of data generated, the inherent need for faster data processing and deep analytics, and the increasing necessity of flexibility and reliability resulting from the vastness of the application spectrum.

Twikit

Seed Round in 2015
Twikit is an enterprise software company with a sharp focus on mass customization and digital manufacturing. We set new standards on how brands and enterprises conceptualize and manufacture products: customizable, on demand and digitally manufactured. The company has its HQ in Antwerp - Belgium and commercial offices in New York City and Stuttgart. The core differentiator of Twikit is the combined knowledge of software, product engineering for digital manufacturing and digital business chains. We work with our partners across the world to enable advanced product individualization by offering seamless end-to-end solutions from ideation to full integration with our enterprise software solutions. Our unique strength is that we integrate product parametrization and UX with digital manufacturing and mass customization at scale into any (existing) business and digital manufacturing flow.

Ancoa Software

Series A in 2015
Ancoa Software is a financial software company that provides contextual surveillance and analytics for exchanges, regulators, and buy- and sell-side firms. Its surveillance platform helps firms take control of their regulatory, reputational, and operational risks across markets, functions, and asset classes. It provides its users with visibility over trading patterns to develop market integrity. Ancoa helps reduce and manage risks of potential insider and wash trading, front-running, and market manipulation practices.

Bluebee

Seed Round in 2015
Bluebee is a leading provider of high performance genomics solutions, enabling research and clinical labs to substantially reduce cost and time-to-diagnose. Bluebee provides a unique cloud-based accelerated genomics platform to enable fast, efficient and affordable processing of large volumes of genomics data. Genetic analyses are currently undergoing extreme changes as a result of revolutionary developments in next generation DNA sequencing technology. While personalized treatment comes with great promises, routine clinical implementation of whole genome based diagnostics is still faced with major technological and biological challenges: the ever-growing amounts of data generated, the inherent need for faster data processing and deep analytics, and the increasing necessity of flexibility and reliability resulting from the vastness of the application spectrum.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.